Interaction of recombinant myocilin with the matricellular protein SPARC: Functional implications

Investigative Ophthalmology and Visual Science

Volumn 52, Issue 1, 2011, Pages 179-189

  Aroca Aguilar, José Daniel ^a,b   Sánchez Sánchez, Francisco ^a,b   Ghosh, Sikha ^c   Fernández Navarro, Ana ^a,b   Coca Prados, Miguel ^c,d   Escribano, Julio ^a,b  

^a Universidad de Castilla La Mancha   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Fundacion de Investigacion Of talmologica   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; FIBRONECTIN; HEVIN; LAMININ; MYOCILIN; NICKEL; OLFACTOMEDIN; OSTEONECTIN; RECOMBINANT MYOCILIN; RECOMBINANT PROTEIN; SCLEROPROTEIN; UNCLASSIFIED DRUG; CALCIUM BINDING PROTEIN; CYTOSKELETON PROTEIN; EYE PROTEIN; GLYCOPROTEIN; HYBRID PROTEIN; SPARCL1 PROTEIN, HUMAN; TRABECULAR MESHWORK-INDUCED GLUCOCORTICOID RESPONSE PROTEIN;

ARTICLE; BINDING AFFINITY; CARBOXY TERMINAL SEQUENCE; CELL STRAIN HEK293; CONTROLLED STUDY; GENE EXPRESSION PROFILING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE MICROSCOPY; MICROARRAY ANALYSIS; MOLECULAR INTERACTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN PURIFICATION; SEQUENCE ALIGNMENT; TWO HYBRID SYSTEM; WESTERN BLOTTING; AMINO ACID SEQUENCE; CELL LINE; CHEMISTRY; FLUORESCENCE MICROSCOPY; GENETICS; KIDNEY; METABOLISM; MOLECULAR GENETICS; POLYMERASE CHAIN REACTION; PRENATAL DEVELOPMENT;

AMINO ACID SEQUENCE; BLOTTING, WESTERN; CALCIUM-BINDING PROTEINS; CELL LINE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYTOSKELETAL PROTEINS; EXTRACELLULAR MATRIX PROTEINS; EYE PROTEINS; GENE EXPRESSION PROFILING; GLYCOPROTEINS; HUMANS; KIDNEY; MICROSCOPY, FLUORESCENCE; MOLECULAR SEQUENCE DATA; OSTEONECTIN; POLYMERASE CHAIN REACTION; PROTEIN BINDING; RECOMBINANT FUSION PROTEINS; RECOMBINANT PROTEINS; TWO-HYBRID SYSTEM TECHNIQUES;

EID: 79952214706     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.09-4866     Document Type: Article

References (53)

1. Escribano J, Ortego J, Coca-Prados M. Isolation and characterization of cell-specific cDNA clones from a subtractive library of the ocular ciliary body of a single normal human donor: transcription and synthesis of plasma proteins. J Biochem (Tokyo). 1995;118: 921-931.
2. Kubota R, Noda S, Wang Y, et al. A novel myosin-like protein (myo-cilin) expressed in the connecting cilium of the photoreceptor: molecular cloning, tissue expression, and chromosomal mapping. Genomics. 1997;41:360-369.
3. Ortego J, Escribano J, Coca-Prados M. Cloning and characterization of subtracted cDNAs from a human ciliary body library encoding TIGR, a protein involved in juvenile open angle glaucoma with homology to myosin and olfactomedin. FEBS Lett. 1997;413: 349-353.
4. Huang W, Jaroszewski J, Ortego J, Escribano J, Coca-Prados M. Expression of the TIGR gene in the iris, ciliary body, and trabecular meshwork of the human eye. Ophthalmic Genet. 2000;21:155-169.
5. Karali A, Russell P, Stefani FH, Tamm ER. Localization of myocilin/ trabecular meshwork-inducible glucocorticoid response protein in the human eye. Invest Ophthalmol Vis Sci. 2000;41:729-740.
6. Fautsch MP, Johnson DH. Characterization of myocilin-myocilin interactions. Invest Ophthalmol Vis Sci. 2001;42:2324-2331.
7. Fautsch MP, Vrabel AM, Peterson SL, Johnson DH. In vitro and in vivo characterization of disulfide bond use in myocilin complex formation. Mol Vis. 2004;10:417-425.
8. Russell P, Tamm ER, Grehn FJ, Picht G, Johnson M. The presence and properties of myocilin in the aqueous humor. Invest Ophthal-mol Vis Sci. 2001;42:983-986.
9. Stone EM, Fingert JH, Alward WL, et al. Identification of a gene that causes primary open angle glaucoma. Science. 1997;275:668-670.
10. Fingert JH, Heon E, Liebmann JM, et al. Analysis of myocilin mutations in 1703 glaucoma patients from five different populations. Hum Mol Genet. 1999;8:899-905.
11. Campos-Mollo E, Sanchez-Sanchez F, Lopez-Garrido MP, Lopez-Sanchez E, Lopez-Martinez F, Escribano J. MYOC gene mutations in Spanish patients with autosomal dominant primary open-angle glaucoma: a founder effect in southeast Spain. Mol Vis. 2007;13: 1666-1673.
12. Sanchez-Sanchez F, Martinez-Redondo F, Aroca-Aguilar JD, Coca-Prados M, Escribano J. Characterization of the intracellular proteolytic cleavage of myocilin and identification of calpain II as a myocilin-processing protease. J Biol Chem. 2007;282: 27810-27824.
13. Coca-Prados M, Escribano J. New perspectives in aqueous humor secretion and in glaucoma: the ciliary body as a multifunctional neuroendocrine gland. Prog Retin Eye Res. 2007;26:239-262.
14. Aroca-Aguilar JD, Sanchez-Sanchez F, Ghosh S, Coca-Prados M, Escribano J. Myocilin mutations causing glaucoma inhibit the in-tracellular endoproteolytic cleavage of myocilin between amino acids Arg226 and Ile227. J Biol Chem. 2005;280:21043-21051.
15. Ezzat MK, Howell KG, Bahler CK, et al. Characterization of monoclonal antibodies against the glaucoma-associated protein myocilin. Exp Eye Res. 2008;87:376-384.
16. Aroca-Aguilar JD, Martinez-Redondo F, Sanchez-Sanchez F, Coca-Prados M, Escribano J. Functional role of proteolytic processing of recombinant myocilin in self-aggregation. Invest Ophthalmol Vis Sci. 2010;51:72-78.
17. Zhou Y, Grinchuk O, Tomarev SI. Transgenic mice expressing the Tyr437His mutant of human myocilin protein develop glaucoma. Invest Ophthalmol Vis Sci. 2008;49:1932-1939.
18. Joe MK, Sohn S, Choi YR, Park H, Kee C. Identification of flotillin-1 as a protein interacting with myocilin: implications for the patho-genesis of primary open-angle glaucoma. Biochem Biophys Res Commun. 2005;336:1201-1206.
19. Filla MS, Liu X, Nguyen TD, et al. In vitro localization of TIGR/ MYOC in trabecular meshwork extracellular matrix and binding to fibronectin. Invest Ophthalmol Vis Sci. 2002;43:151-161.
20. Ueda J, Wentz-Hunter K, Yue BY. Distribution of myocilin and extracellular matrix components in the juxtacanalicular tissue of human eyes. Invest Ophthalmol Vis Sci. 2002;43:1068-1076.
21. Fautsch MP, Vrabel AM, Johnson DH. The identification of myoci-lin-associated proteins in the human trabecular meshwork. Exp Eye Res. 2006;82:1046-1052.
22. Torrado M, Trivedi R, Zinovieva R, Karavanova I, Tomarev SI. Optimedin: a novel olfactomedin-related protein that interacts with myocilin. Hum Mol Genet. 2002;11:1291-1301.
23. Li Y, Aroca-Aguilar JD, Ghosh S, Sanchez-Sanchez F, Escribano J, Coca-Prados M. Interaction of myocilin with the C-terminal region of hevin. Biochem Biophys Res Commun. 2006;339:797-804.
24. Girard JP, Springer TA. Modulation of endothelial cell adhesion by hevin, an acidic protein associated with high endothelial venules. J Biol Chem. 1996;271:4511-4517.
25. Brekken RA, Sage EH. SPARC, a matricellular protein: at the crossroads of cell-matrix communication. Matrix Biol. 2001;19: 816-827.
26. Vannahme C, Smyth N, Miosge N, et al. Characterization of SMOC-1, a novel modular calcium-binding protein in basement membranes. J Biol Chem. 2002;277:37977-37986.
27. Vannahme C, Gosling S, Paulsson M, Maurer P, Hartmann U. Characterization of SMOC-2, a modular extracellular calcium-binding protein. Biochem J. 2003;373:805-814.
28. Lane TF, Sage EH. The biology of SPARC, a protein that modulates cell-matrix interactions. FASEB J. 1994;8:163-173.
29. Yan Q, Sage EH. SPARC, a matricellular glycoprotein with important biological functions. J Histochem Cytochem. 1999;47:1495-1506.
30. Motamed K, Sage EH. SPARC inhibits endothelial cell adhesion but not proliferation through a tyrosine phosphorylation-dependent pathway. J Cell Biochem. 1998;70:543-552.
31. Bornstein P, Sage EH. Matricellular proteins: extracellular modulators of cell function. Curr Opin Cell Biol. 2002;14:608-616.
32. Bradshaw AD, Sage EH. SPARC, a matricellular protein that functions in cellular differentiation and tissue response to injury. J Clin Invest. 2001;107:1049-1054.
33. Switzer RC III, Merril CR, Shifrin S. A highly sensitive silver stain for detecting proteins and peptides in polyacrylamide gels. Anal Biochem. 1979;98:231-237.
34. Aroca-Aguilar JD, Sanchez-Sanchez F, Martinez-Redondo F, Coca-Prados M, Escribano J. Heterozygous expression of myocilin glaucoma mutants increases secretion of the mutant forms and reduces extracellular processed myocilin. Mol Vis. 2008;14:2097-2108.
35. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248-254.
36. Ghosh S, Freitag AC, Martin-Vasallo P, Coca-Prados M. Cellular distribution and differential gene expression of the three alpha subunit isoforms of the Na,K-ATPase in the ocular ciliary epithelium. J Biol Chem. 1990;265:2935-2940.
37. Hambrock HO, Nitsche DP, Hansen U, et al. SC1/hevin: an extracellular calcium-modulated protein that binds collagen I. J Biol Chem. 2003;278:11351-11358.
38. Estojak J, Brent R, Golemis EA. Correlation of two-hybrid affinity data with in vitro measurements. Mol Cell Biol. 1995;15: 5820-5829.
39. Zhu J, Kahn CR. Analysis of a peptide hormone-receptor interaction in the yeast two-hybrid system. Proc Natl Acad Sci USA. 1997;94:13063-13068.
40. Rhee DJ, Haddadin RI, Kang MH, Oh DJ. Matricellular proteins in the trabecular meshwork. Exp Eye Res. 2009;88:694-703.
41. Yan Q, Clark JI, Sage EH. Expression and characterization of SPARC in human lens and in the aqueous and vitreous humors. Exp Eye Res. 2000;71:81-90.
42. Gilbert RE, Cox AJ, Kelly DJ, et al. Localization of secreted protein acidic and rich in cysteine (SPARC) expression in the rat eye. Connect Tissue Res. 1999;40:295-303.
43. Rhee DJ, Fariss RN, Brekken R, Sage EH, Russell P. The matricellular protein SPARC is expressed in human trabecular meshwork. Exp Eye Res. 2003;77:601-607.
44. Goldwich A, Scholz M, Tamm ER. Myocilin promotes substrate adhesion, spreading and formation of focal contacts in podocytes and mesangial cells. Histochem Cell Biol. 2009;131:167-180.
45. Lane TF, Sage EH. Functional mapping of SPARC: peptides from two distinct Ca+(+)-binding sites modulate cell shape. J Cell Biol. 1990;111:3065-3076.
46. Murphy-Ullrich JE, Lane TF, Pallero MA, Sage EH. SPARC mediates focal adhesion disassembly in endothelial cells through a follistatin-like region and the Ca(2+)-binding EF-hand.J Cell Biochem. 1995; 57:341-350.
47. Wentz-Hunter K, Kubota R, Shen X, Yue BY. Extracellular myocilin affects activity of human trabecular meshwork cells. J Cell Physiol. 2004;200:45-52.
48. Peters DM, Herbert K, Biddick B, Peterson JA. Myocilin binding to Hep II domain of fibronectin inhibits cell spreading and incorporation of paxillin into focal adhesions. Exp CellRes. 2005;303:218-228.
49. Yao HY, Cheng CY, Fan BJ, et al. [Polymorphisms of myocilin and optineurin in primary open angle glaucoma patients]. Zhonghua YiXueZaZhi. 2006;86:554-559
50. Mann K, Deutzmann R, Paulsson M, Timpl R. Solubilization of protein BM-40 from a basement membrane tumor with chelating agents and evidence for its identity with osteonectin and SPARC. FEBS Lett. 1987;218:167-172.
51. Tyree B. The partial degradation of osteonectin by a bone-derived metalloprotease enhances binding to type I collagen. J Bone Miner Res. 1989;4:877-883.
52. Otsuka K, Yao KL, Wasi S, et al. Biosynthesis of osteonectin by fetal porcine calvarial cells in vitro.JBiol Chem. 1984;259:9805-9812.
53. Thompson JD, Higgins DG, Gibson TJ. Clustal W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 1994;22:4673-4680.